AP2009004954A0 - 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer - Google Patents

2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer

Info

Publication number
AP2009004954A0
AP2009004954A0 AP2009004954A AP2009004954A AP2009004954A0 AP 2009004954 A0 AP2009004954 A0 AP 2009004954A0 AP 2009004954 A AP2009004954 A AP 2009004954A AP 2009004954 A AP2009004954 A AP 2009004954A AP 2009004954 A0 AP2009004954 A0 AP 2009004954A0
Authority
AP
ARIPO
Prior art keywords
pyrimidinederivatives
hsp
cer
pyrrolo
dihydro
Prior art date
Application number
AP2009004954A
Other languages
English (en)
Inventor
Luke Raymond Zehnder
Buwen Huang
Michael John Bennett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP2009004954A0 publication Critical patent/AP2009004954A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2009004954A 2007-02-06 2008-01-25 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer AP2009004954A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88843307P 2007-02-06 2007-02-06
US2066108P 2008-01-11 2008-01-11
PCT/IB2008/000200 WO2008096218A1 (fr) 2007-02-06 2008-01-25 Dérivés de 2-amino-5,7-dihydro-6h-pyrrolo[3,4-d]pyrimidine en tant qu'inhibiteurs de la hsp 90 pour le traitement du cancer

Publications (1)

Publication Number Publication Date
AP2009004954A0 true AP2009004954A0 (en) 2009-08-31

Family

ID=39367692

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004954A AP2009004954A0 (en) 2007-02-06 2008-01-25 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer

Country Status (22)

Country Link
US (1) US20100093696A1 (fr)
EP (1) EP2118111B1 (fr)
JP (1) JP4523073B2 (fr)
KR (1) KR20090116789A (fr)
AP (1) AP2009004954A0 (fr)
AT (1) ATE502944T1 (fr)
AU (1) AU2008212645A1 (fr)
BR (1) BRPI0807165A2 (fr)
CA (1) CA2677365A1 (fr)
CO (1) CO6220971A2 (fr)
CR (1) CR10963A (fr)
CU (1) CU20090141A7 (fr)
DE (1) DE602008005715D1 (fr)
DO (1) DOP2009000200A (fr)
EA (1) EA200970669A1 (fr)
EC (1) ECSP099565A (fr)
IL (1) IL200169A0 (fr)
MA (1) MA31170B1 (fr)
MX (1) MX2009008386A (fr)
NI (1) NI200900155A (fr)
TN (1) TN2009000329A1 (fr)
WO (1) WO2008096218A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2331544A1 (fr) 2008-08-13 2011-06-15 Pfizer Inc. Composés 2-amino pyrimidine comme inhibiteurs puissants de l'hsp-90
GB0907284D0 (en) 2009-04-28 2009-06-10 Queen Mary & Westfield College Compounds for inducing cellular apoptosis
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
PH12012501556A1 (en) 2009-12-30 2012-10-22 Arqule Inc Substituted naphthalenyl-pyrimidine compounds
EP2752201A1 (fr) * 2013-01-04 2014-07-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibiteurs de HSP90 C-terminal pour traiter les adénomes hypophysaires
US9447026B2 (en) 2013-03-14 2016-09-20 Kalyra Pharmaceuticals, Inc. Bicyclic analgesic compounds
CA2932039A1 (fr) 2013-12-12 2015-06-18 Kalyra Pharmaceuticals, Inc. Composes d'alkyle bicyclique et synthese
CN113336653A (zh) 2014-03-07 2021-09-03 里科瑞尔姆Ip控股有限责任公司 螺桨烷衍生物及合成
JP6779867B2 (ja) * 2014-06-13 2020-11-04 ユマ セラピューティクス，インコーポレーテッド ピリミジン化合物およびその使用方法
US10308609B2 (en) 2014-09-17 2019-06-04 Zeno Royalties & Milestones, LLC Bicyclic compounds
US10227029B2 (en) * 2015-08-07 2019-03-12 Kawasaki Jukogyo Kabushiki Kaisha Container holder attached to utility vehicle
US11242327B2 (en) 2017-05-15 2022-02-08 Recurium Ip Holdings, Llc Analgesic compounds
WO2020243457A1 (fr) * 2019-05-29 2020-12-03 Viogen Biosciences, Llc Composés et leurs utilisations thérapeutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
JP3663382B2 (ja) 2000-02-15 2005-06-22 スージェン・インコーポレーテッド ピロール置換２−インドリノン蛋白質キナーゼ阻害剤
EP1470121B1 (fr) * 2002-01-23 2012-07-11 Bayer HealthCare LLC Derives pyrimidine en tant qu'inhibiteurs de kinase rho
US7312330B2 (en) * 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
AU2006230447A1 (en) * 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors

Also Published As

Publication number Publication date
CR10963A (es) 2009-08-27
IL200169A0 (en) 2010-04-15
CA2677365A1 (fr) 2008-08-14
DE602008005715D1 (de) 2011-05-05
BRPI0807165A2 (pt) 2014-05-06
TN2009000329A1 (fr) 2010-12-31
MX2009008386A (es) 2009-10-16
CU20090141A7 (es) 2011-04-26
DOP2009000200A (es) 2009-09-15
AU2008212645A1 (en) 2008-08-14
CO6220971A2 (es) 2010-11-19
EA200970669A1 (ru) 2010-02-26
MA31170B1 (fr) 2010-02-01
EP2118111A1 (fr) 2009-11-18
JP2010518066A (ja) 2010-05-27
JP4523073B2 (ja) 2010-08-11
US20100093696A1 (en) 2010-04-15
NI200900155A (es) 2010-06-30
ATE502944T1 (de) 2011-04-15
WO2008096218A1 (fr) 2008-08-14
ECSP099565A (es) 2009-09-29
KR20090116789A (ko) 2009-11-11
EP2118111B1 (fr) 2011-03-23

Similar Documents

Publication Publication Date Title
AP2009004954A0 (en) 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer
IL195238A0 (en) Pyrazolo [1,5-a]pyrimidines as cdk inhibitors
IL257418A (en) Methods for treating addiction
IL211136A0 (en) Pyrido [5,4-d] pyrimidines as cell proliferation inhibitors
HRP20130799T1 (en) 8-heteroaryl-3-alkyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as pi-3 kinases inhibitors
TWI372625B (en) Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
PT2041138E (pt) Inibidores de pirrolotriazina quinase
GB0814904D0 (en) Search, transfer and bookign tool for multiple reward programs
ZA201004368B (en) Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors
IL226486A (en) Converted pyrazolopyrimidine compounds
SI1893612T1 (sl) Pirolo b piridin derivati kot protein kinazni inhibitorji
IL194583A0 (en) Imidazo compounds
PL2004654T3 (pl) Pochodne pirazolopirymidyny do stosowania jako antagonisty kinazy
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
ZA200710192B (en) Substituted arylpyrazoles for use against parasitites
SI2124944T1 (sl) Derivati pirazolo b piridina kot inhibitorji fosfodiesteraze
EP2224803A4 (fr) Spiropipéridines utilisables en tant qu'inhibiteurs de la tryptase
EP2012791A4 (fr) 7,9-dihydro-purin-8-one et analogues associés utilisés en tant qu'inhibiteurs de hsp90
EP2142542A4 (fr) Nouveaux composés d'imidazo [4,5-b] pyridine-7-carboxamides 704
SI2004654T1 (sl) Pirazolopirimidinski derivati za uporabo kot kinazni antagonisti
ZA200805028B (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
GB0810059D0 (en) Paint supply system
PT2471559E (pt) Método antiviral
ZA200906166B (en) 2-amino-5, 7-dihydro-6H-pyrrolo [3, 4-D] pyrimidine derivatives as HSP-90 inhibitors for treating cancer
AP2008004437A0 (en) Pyrazolo Ä4,3-DÜ pyrimidin-5-yl) derivative used as PDE5 inhibitors